Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) (‘Cardiol’ or the ‘Company’), a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart disease, confirmed today that it has successfully closed its previously announced public offering (the ‘Offering’) of 8,437,500…
Stillwater Critical Minerals (TSXV:PGE,OTCQB:PGEZF) has signed a non-binding memorandum of understanding (MOU) with private company US Strategic Metals (USSM)…
West High Yield (W.H.Y.) Resources Ltd. (TSXV: WHY) (the ‘Company’ or ‘West High Yield’) is pleased to announce that it…
Dynasty Gold Corp. (TSXV: DYG) (FSE: D5G1) (OTC Pink: DGDCF) (‘Dynasty’ or the ‘Company’) is pleased to report the…
Despite starting the year strong with prices trending above US$106 per pound, uranium values have spent much of the…
Taiwan Semiconductor (TSMC) (NYSE:TSM,TPE:2330), the world’s largest contract chipmaker, reported a strong 39.6 percent year-over-year increase in revenue for…
Cyclone Metals Limited (ASX: CLE) (Cyclone or the Company) is pleased to announce that Iron Bear completes pilot pellet…
CleanTech Lithium PLC (‘CTL’, ‘CleanTech Lithium’ or the ‘Company’), an exploration and development company advancing lithium projects in Chile…
The global initial public offering (IPO) market has displayed remarkable resilience in the third quarter of 2024, despite ongoing…